# Aashka Hospital (NSE: AASHKA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AASHKA · Pivot · prices to 21 Oct 2026

With a market capitalisation of ₹190 Cr, it ranks 2305th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 3.2% in FY26. Promoters held 61.33% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹190 Cr |
| ROE | 3.2% (FY26) |
| ROCE | 4.1% (FY26) |
| Debt to equity | 0.08 |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | — | — | −₹0 Cr | −233.3% | ₹0.00 |
| Q3 FY26 | — | — | −₹0 Cr | — | ₹0.00 |
| Q2 FY26 | — | — | −₹0 Cr | — | ₹0.00 |
| Q1 FY26 | — | — | −₹0 Cr | — | ₹0.00 |
| Q4 FY25 | — | — | ₹0 Cr | — | ₹0.00 |
| Q3 FY25 | — | — | −₹0 Cr | — | ₹0.00 |
| Q2 FY25 | — | — | −₹0 Cr | — | ₹0.00 |
| Q1 FY25 | — | — | −₹0 Cr | — | ₹0.00 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹23 Cr | ₹3 Cr |
| FY24 | ₹23 Cr | ₹2 Cr |
| FY23 | ₹19 Cr | −₹3 Cr |
| FY22 | ₹40 Cr | ₹2 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 61.33%
- Non-institutions: 38.67%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Coral Labs](https://app.pivotnow.in/stock/CORALAB) | — | ₹196 Cr | — | — |
| [OXYGENTA PHARMA](https://app.pivotnow.in/stock/OXYGENTAPH) | — | ₹185 Cr | — | — |
| [Accretion Nutra](https://app.pivotnow.in/stock/ANL) | — | ₹184 Cr | — | — |
| [Brooks Laboratories](https://app.pivotnow.in/stock/BROOKS) | ₹61.79 | ₹182 Cr | 7.4 | — |
| [Earkart](https://app.pivotnow.in/stock/EARKART) | — | ₹182 Cr | — | — |
| [Novelix Pharma](https://app.pivotnow.in/stock/NOVELIX) | — | ₹181 Cr | — | — |

## Questions and answers

### What is the market cap of Aashka Hospital?

Aashka Hospital's market capitalisation is ₹190 Cr (₹190 Cr) at the 21 Oct 2026 close, ranking 2305th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Aashka Hospital?

Return on equity was 3.2% in FY26 and return on capital employed was 4.1% in FY26 (standalone figures).

### Is Aashka Hospital a debt-free company?

No. Aashka Hospital's debt-to-equity ratio was 0.08 in FY26, with total debt of ₹7 Cr.

### What is the shareholding pattern of Aashka Hospital?

As of 31 Mar 2026: promoters 61.33%, non-institutions 38.67%.

### Who are Aashka Hospital's competitors?

The listed Pharma & Healthcare companies closest to Aashka Hospital by market cap are Coral Labs, OXYGENTA PHARMA, Accretion Nutra, Brooks Laboratories, Earkart and Novelix Pharma.

### Is Aashka Hospital a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Aashka Hospital's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AASHKA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.